CVM CEL SCI CORP Insider Trading

CEO Geert R Kersten bought 300.0K shares of CVM at $1.20 on 2026-05-14, increasing holdings +2598.1% to 311.5K shares.

Geert R Kersten, CEO of CEL SCI CORP, purchased 300,000 shares at $1.20 for $360,000.00, a substantial accumulation that grew his stake from 11,547 shares to 311,547 shares. The current stock price of $1.60 is -88.1% from the 52-week high of $13.48, and the stock has declined -67.7% over the past 30 days and -66.5% over 90 days. At this same ticker, his prior buy on 2026-01-22 returned -8.8% in 30 days, and his 2025-12-04 purchase returned -13.6% in 30 days, while earlier buys on 2025-07-25 and 2024-05-08 showed positive 90-day returns of +31.2% and +2403.6% respectively. The company reported quarterly revenue of $77,403.00 with net income of $-5,469,446.00, reflecting unprofitability over its most recent full fiscal year, though annual revenue growth was +65.4% year-over-year. This large open-market purchase by the CEO during a period of severe stock depreciation and negative profitability warrants close attention to the company's operational trajectory and the rationale behind this capital deployment.

CEO Geert Kersten buys 100,000 shares at $1.19 as stock trades 91% below 52-week high; fifth open-market purchase in two years despite mixed track record.

Geert Kersten, CEO of CEL SCI CORP, deployed over $119,000 to acquire 100,000 shares on the open market, expanding his direct stake by roughly 82 percent and marking his fifth open-market purchase at this company in just over two years. The stock is trading well below its 52-week high and has declined sharply over the past three months, presenting a classic opportunity for insider accumulation during weakness. However, Kersten's prior trading record at CVM is decidedly mixed: of his four previous open-market purchases, two were followed by stock appreciation over the subsequent quarter while two were preceded by declines, suggesting his timing at this company has been inconsistent. The company itself remains unprofitable with negative earnings, though annual revenue showed growth compared to the prior year—a thin positive in a otherwise challenged financial profile. This is noteworthy not for "conviction" but for pattern: a CEO who continues to buy his own company shares despite a mixed track record and the stock's severe decline merits scrutiny into whether he sees genuine value or is simply catching a falling knife.